Welcome to Cyxone!

Cyxone develops new drugs based upon a natural plant protein

Cyxone AB is a biopharmaceutical company developing drugs based on cyclotides, a natural class of plant proteins, for immune-related diseases. Cyxone’s focus is to bring its drug candidate against MS, T20K, through preclinical studies and phase I clinical trials.

Upcoming events

BioEurope Spring

Start date: March 12 2018

End date: March 14 2018

Cyxone will attend the BioEurope Spring event in Amsterdam, The Netherlands, on 12-14 March.